Shuai Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuai Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Xiaochi Chang
Department of Periodontology, National Engineering Laboratory for Digital and Material Technology of Stomatology Peking University School and Hospital of Stomatology Beijing China
3 shared publications Fengyi Zhou
Department of Stomatology, the Affiliated Hospital of Qingdao University, Qingdao, China; School of Stomatology of Qingdao University, Qingdao, China; Dental Digital Medicine & 3D Printing Engineering Laboratory of Qingdao, Qingdao, China
2 shared publications- Jing Deng
Department of Stomatology, The Affiliated hospital of Qingdao University, Qingdao, China
2 shared publications Nan Wang
School of Stomatology of Qingdao University Qingdao China
2 shared publicationsZhihao Geng
Qingdao Univ, Dept Stomatol, Affiliated Hosp, Qingdao, Peoples R China
2 shared publications- Fengyi Zhou
Qingdao Univ, Sch Stomatol, Qingdao, Peoples R China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 3 March 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
The oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications
The human oral microbiome is a highly diverse ecosystem with important roles in oral and systemic health. Beyond dental caries and periodontitis, oral dysbiosis has been increasingly implicated in the development of multiple non-communicable diseases. To systematically synthesize evidence on the mechanisms linking oral dysbiosis to systemic diseases and to summarize its diagnostic and therapeutic implications. A systematic review was performed using major electronic databases. We screened 1,128 records and included 104 studies that met predefined eligibility criteria. Evidence indicates that oral dysbiosis may influence systemic health through several mechanisms, including hematogenous dissemination of oral pathogens and virulence factors (e.g. lipopolysaccharide), chronic systemic inflammation, molecular mimicry in autoimmune disorders, and microbial metabolic byproducts. The reviewed studies support associations between oral microbiome alterations and atherosclerotic cardiovascular disease, type 2 diabetes, Alzheimer’s disease, rheumatoid arthritis, and gastrointestinal cancers. The literature also highlights the promise of non-invasive oral microbiome-based biomarkers for early detection and disease monitoring. Emerging microbiome-modulating interventions, including probiotics, prebiotics, and bacteriophage therapy, show potential for restoring oral eubiosis and improving systemic outcomes. Oral dysbiosis is an important regulator of systemic disease processes and a promising target for diagnosis, prevention, and therapy. Integrating oral health and oral microbiome assessment into broader disease management may improve outcomes, although methodological standardization and stronger causal evidence are still needed.
- 3 March 2026
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 18 (1)
Top Cited PapersOpen AccessThe oral microbiome as a regulatory hub for systemic health: a systematic review of mechanistic links and clinical implications
The human oral microbiome is a highly diverse ecosystem with important roles in oral and systemic health. Beyond dental caries and periodontitis, oral dysbiosis has been increasingly implicated in the development of multiple non-communicable diseases. To systematically synthesize evidence on the mechanisms linking oral dysbiosis to systemic diseases and to summarize its diagnostic and therapeutic implications. A systematic review was performed using major electronic databases. We screened 1,128 records and included 104 studies that met predefined eligibility criteria. Evidence indicates that oral dysbiosis may influence systemic health through several mechanisms, including hematogenous dissemination of oral pathogens and virulence factors (e.g. lipopolysaccharide), chronic systemic inflammation, molecular mimicry in autoimmune disorders, and microbial metabolic byproducts. The reviewed studies support associations between oral microbiome alterations and atherosclerotic cardiovascular disease, type 2 diabetes, Alzheimer’s disease, rheumatoid arthritis, and gastrointestinal cancers. The literature also highlights the promise of non-invasive oral microbiome-based biomarkers for early detection and disease monitoring. Emerging microbiome-modulating interventions, including probiotics, prebiotics, and bacteriophage therapy, show potential for restoring oral eubiosis and improving systemic outcomes. Oral dysbiosis is an important regulator of systemic disease processes and a promising target for diagnosis, prevention, and therapy. Integrating oral health and oral microbiome assessment into broader disease management may improve outcomes, although methodological standardization and stronger causal evidence are still needed.
- 13 February 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 161, 105912
D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways
- 13 February 2024
- Published by Elsevier in Archives of Oral Biology
- Vol. 161, 105912
D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways
- 30 December 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 175, 105964
Effect of Enterococcus faecalis on osteoclastogenesis under cobalt-mimicked hypoxia in vitro
- 30 December 2022
- Published by Elsevier in Microbial Pathogenesis
- Vol. 175, 105964
Effect of Enterococcus faecalis on osteoclastogenesis under cobalt-mimicked hypoxia in vitro
- 17 January 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (2) , 425-433
Semaphorin 3A attenuates the hypoxia suppression of osteogenesis in periodontal ligament stem cells
Objective and Background The occurrence and development of periodontitis are closely related to hypoxia of the periodontal microenvironment. Periodontal ligament stem cells (PDLSCs) are considered to have potential to regenerate periodontal tissues. Semaphorin 3A (Sema3A) plays an essential role in promoting osteogenesis. However, the effect of Sema3A on osteogenesis of PDLSCs under hypoxia remains unclear. The aim of this study was to investigate the effect of Sema3A on osteogenesis of PDLSCs under hypoxia. Methods Isolated PDLSCs were identified using flow cytometry. Adipogenic differentiation potential was identified by oil red O staining. Osteogenesis was measured using Alizarin Red S staining and ALP staining. Intracellular hypoxia was induced using cobalt chloride (CoCl2). The expression level of hypoxia-inducible factor-1α (HIF-1α) was detected via ELISA. Expression of osteogenic markers and Sema3A was analyzed using western blot and real-time PCR. Results The proliferation and osteogenesis of PDLSCs were markedly inhibited with increased concentrations of CoCl2. Under the treatment with a low concentration of CoCl2, expression of related osteogenic markers and Sema3A decreased in a time-dependent manner. ARS and ALP staining results also showed that osteogenic calcification decreased under hypoxia. Apigenin, an inhibitor of HIF-1α, effectively up-regulated expression of Sema3A and osteogenic markers with CoCl2 treatment. Moreover, exogenous Sema3A significantly increased the expression of osteogenesis-related markers and mineralization of PDLSCs according to ALP and ARS staining with CoCl2 treatment. Conclusions Hypoxia markedly inhibited osteogenesis of PDLSCs. Sema3A explicitly attenuated the hypoxia suppression of osteogenesis in PDLSCs.
- 17 January 2022
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (2) , 425-433
Semaphorin 3A attenuates the hypoxia suppression of osteogenesis in periodontal ligament stem cells
Objective and Background The occurrence and development of periodontitis are closely related to hypoxia of the periodontal microenvironment. Periodontal ligament stem cells (PDLSCs) are considered to have potential to regenerate periodontal tissues. Semaphorin 3A (Sema3A) plays an essential role in promoting osteogenesis. However, the effect of Sema3A on osteogenesis of PDLSCs under hypoxia remains unclear. The aim of this study was to investigate the effect of Sema3A on osteogenesis of PDLSCs under hypoxia. Methods Isolated PDLSCs were identified using flow cytometry. Adipogenic differentiation potential was identified by oil red O staining. Osteogenesis was measured using Alizarin Red S staining and ALP staining. Intracellular hypoxia was induced using cobalt chloride (CoCl2). The expression level of hypoxia-inducible factor-1α (HIF-1α) was detected via ELISA. Expression of osteogenic markers and Sema3A was analyzed using western blot and real-time PCR. Results The proliferation and osteogenesis of PDLSCs were markedly inhibited with increased concentrations of CoCl2. Under the treatment with a low concentration of CoCl2, expression of related osteogenic markers and Sema3A decreased in a time-dependent manner. ARS and ALP staining results also showed that osteogenic calcification decreased under hypoxia. Apigenin, an inhibitor of HIF-1α, effectively up-regulated expression of Sema3A and osteogenic markers with CoCl2 treatment. Moreover, exogenous Sema3A significantly increased the expression of osteogenesis-related markers and mineralization of PDLSCs according to ALP and ARS staining with CoCl2 treatment. Conclusions Hypoxia markedly inhibited osteogenesis of PDLSCs. Sema3A explicitly attenuated the hypoxia suppression of osteogenesis in PDLSCs.
- Open Access
- 9 April 2020
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 19 (6) , 3805-3813
Antibacterial effect of chitosan and its derivative on Enterococcus faecalis associated with endodontic infection
Chitosan and its derivatives have been increasingly used for bacteriostasis. To date, the effect of chitosan and N‑(2‑hydroxyl) propyl‑3‑trimethyl ammonium chitosan chloride (HTCC) on Enterococcus faecalis (E. faecalis) associated with endodontic infection has remained to be determined. Chitosan and HTCC were serially diluted with double‑distilled water (DDW) or PBS at concentrations of 20‑2,500 µg/ml. Various strains of E. faecalis (American Type Tissue Collection no. 29212, as well as isolated strains P25RC and P52Sa) in plankton were adjusted to an optical density at 600 nm of 0.10 and treated with chitosan or HTCC. A colony‑forming unit assay was used to determine the concentration of residual bacteria after treatment. Furthermore, E. faecalis biofilms were cultured on coverslips and treated with chitosan or HTCC. The coverslips were rinsed, stained using Live/dead® BacLight™ bacterial viability kit and observed under an inverted fluorescence microscope. In addition, biofilms on dentine blocks were prepared and observed under a scanning electron microscope. MC3T3‑E1 pre‑osteoblasts were seeded on 96‑well plates and treated with chitosan or HTCC at various concentrations. The cytotoxicity of chitosan and HTCC on MC3T3‑E1 pre‑osteoblasts was detected using a Cell Counting Kit‑8 assay after 24, 48 and 72 h of treatment. The results revealed that the final minimum bactericidal concentrations (MBC) of chitosan and HTCC dissolved in DDW were 70 and 140 µg/ml, respectively. Chitosan and HTCC in DDW exerted a significantly greater antibacterial effect as compared with that in PBS (P<0.05). At the MBC, chitosan and HTCC in DDW, but particularly chitosan, had a significant antibacterial effect on E. faecalis biofilm. Chitosan exhibited no cytotoxicity to MC3T3‑E1 pre‑osteoblasts at a concentration of <625 µg/ml, while HTCC inhibited the proliferation of the cells in the concentration range of 39‑10,000 µg/ml. In conclusion, chitosan and HTCC exhibited prominent antibacterial properties on E. faecalis in the planktonic state and as a biofilm via charge interaction, indicating their potential for application in root canal disinfection and fillings.
- 9 April 2020
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 19 (6) , 3805-3813
Open AccessAntibacterial effect of chitosan and its derivative on Enterococcus faecalis associated with endodontic infection
Chitosan and its derivatives have been increasingly used for bacteriostasis. To date, the effect of chitosan and N‑(2‑hydroxyl) propyl‑3‑trimethyl ammonium chitosan chloride (HTCC) on Enterococcus faecalis (E. faecalis) associated with endodontic infection has remained to be determined. Chitosan and HTCC were serially diluted with double‑distilled water (DDW) or PBS at concentrations of 20‑2,500 µg/ml. Various strains of E. faecalis (American Type Tissue Collection no. 29212, as well as isolated strains P25RC and P52Sa) in plankton were adjusted to an optical density at 600 nm of 0.10 and treated with chitosan or HTCC. A colony‑forming unit assay was used to determine the concentration of residual bacteria after treatment. Furthermore, E. faecalis biofilms were cultured on coverslips and treated with chitosan or HTCC. The coverslips were rinsed, stained using Live/dead® BacLight™ bacterial viability kit and observed under an inverted fluorescence microscope. In addition, biofilms on dentine blocks were prepared and observed under a scanning electron microscope. MC3T3‑E1 pre‑osteoblasts were seeded on 96‑well plates and treated with chitosan or HTCC at various concentrations. The cytotoxicity of chitosan and HTCC on MC3T3‑E1 pre‑osteoblasts was detected using a Cell Counting Kit‑8 assay after 24, 48 and 72 h of treatment. The results revealed that the final minimum bactericidal concentrations (MBC) of chitosan and HTCC dissolved in DDW were 70 and 140 µg/ml, respectively. Chitosan and HTCC in DDW exerted a significantly greater antibacterial effect as compared with that in PBS (P<0.05). At the MBC, chitosan and HTCC in DDW, but particularly chitosan, had a significant antibacterial effect on E. faecalis biofilm. Chitosan exhibited no cytotoxicity to MC3T3‑E1 pre‑osteoblasts at a concentration of <625 µg/ml, while HTCC inhibited the proliferation of the cells in the concentration range of 39‑10,000 µg/ml. In conclusion, chitosan and HTCC exhibited prominent antibacterial properties on E. faecalis in the planktonic state and as a biofilm via charge interaction, indicating their potential for application in root canal disinfection and fillings.